Picture of CSL logo

CSL — CSL Cashflow Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Annual cashflow statement for CSL, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

2022
June 30th
2023
June 30th
2024
June 30th
2025
June 30th
2026
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line2,7802,6633,3753,724-4,087
Depreciation
Non-Cash Items6486758097348,018
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1,467-1,568-2,358-1,914-1,460
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities2,6292,6012,7643,5613,512
Capital Expenditures-1,248-1,692-1,258-998-1,280
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-388-10,151-11489
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Change in Net Investments
Purchase of Investments
Cash from Investing Activities-1,636-11,843-1,259-850-1,271
Financing Cash Flow Items2.5-154-74-100-155
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities7,676456-1,284-2,241-2,828
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash8,604-8,825134514-644